Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Michael Sardano is PRESIDENT AND GENERAL COUNSEL at Sensus Healthcare. OQRO lists 9 transactions filed with the SEC under this name, the latest on Dec 16, 2025, each linked to the official Form 4.
PRESIDENT AND GENERAL COUNSEL
Disclosures on record
9
Companies involved
1
5 buys, median −7.2 pts vs S&P 500, beat it 2 of 5 times.
Average 0.0 pts vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Feb 10, 2025 to Nov 19, 2025, measured from the first close after the filing. Past results, not a forecast.
5 purchases disclosed; 40% of the 5 measured at 90 days finished ahead of the index. $1,000 placed after each of the 2 purchases disclosed since 2025-11-14 would be worth $1.2K today ($2K put in); the same in the S&P 500 (SPY): $2.3K.
Not ranked: fewer than 10 purchases measured at 90 days. The middle of the 82 ranked insiders is −5.5 pts (median, against the S&P 500).
Sensus HealthcareSRTS
9 disclosures · Feb 2025 – Dec 2025 · 8 bought
Dec 12, 202540Kdisclosed Dec 16
DetailsOfficial recordNov 18, 2025Bought~$3.8Kdisclosed Nov 19
DetailsOfficial recordEqual weight counts every purchase once; by size counts it for its disclosed dollars. Both are measured from the first close after it was reported. Past results describe the past, not a forecast. How this is measured · Leaderboard
Nov 11, 2025Bought~$1Kdisclosed Nov 18
DetailsOfficial recordNov 11, 2025Bought~$4.3Kdisclosed Nov 18
DetailsOfficial recordNov 11, 2025Bought~$3.3Kdisclosed Nov 18
DetailsOfficial recordNov 11, 2025Bought~$3.3Kdisclosed Nov 13
DetailsOfficial recordNov 11, 2025Bought~$992disclosed Nov 13
DetailsOfficial recordAug 13, 2025Bought~$3.4Kdisclosed Aug 14
DetailsOfficial recordFeb 10, 2025Bought~$6K
DetailsOfficial recordAs of the latest filing on , Michael Sardano reported holding 159,839 shares of Sensus Healthcare (SRTS), worth about $372K at the last close of $2 (Nov 13, 2026): 158,839 held directly and 1,000 through a spouse. In the last 12 months, Michael Sardano bought $12K in 4 open-market purchases.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Sensus Healthcare SRTS | 159,839 | 159K direct · 1,000 spouse | $2 | $372K | Dec 12, 2025 |
Is this Michael Sardano’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Dec 12, 2025, Michael Sardano reported holding 159,839 shares of Sensus Healthcare (SRTS), of which 1,000 are held indirectly. At the last close of $2 on Nov 13, 2026, that is about $372K. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Michael Sardano reported 4 open-market purchases worth $12K, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Michael Sardano bought shares on the open market in 2023 and 2025. Sales in 1 of the 5 years since 2022.
In SEC filings since 2022: the latest open-market purchase is from 2025; the latest open-market sale is from 2022.
Sensus Healthcare (SRTS), from 2022 to 2025: 11 purchases and 1 sale.
Michael Sardano bought shares on the open market in 2023 and 2025. Sales in 1 of the 5 years since 2022.
Michael Sardano reported 11 open-market purchases and 1 sale since 2022; purchases in 2 different years, most recently 2025.
| Year | Bought | Sold |
|---|---|---|
| 2025 | $26K8×8 trades | — |
| 2023 | $9.8K3×3 trades | — |
| 2022 | — | $71K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Michael Sardano reported 11 open-market purchases and 1 sale here, 2022 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.